Wednesday, 18 September 2019

The Asia Pacific cardiovascular devices market to reach $16,107.3 Mn in 2027

23 August 2019 | News

The market has raised from US$ 8,852.6 Mn in 2018 and is estimated to grow with a CAGR of 7.0% from 2019-2027.

Photo credit: envisioninteligence

Photo credit: envisioninteligence

The "Asia Pacific Cardiovascular Devices Market to 2027 - Regional Analysis and Forecasts By Device, Pacemaker, Stent, Defibrillator, Cardiac Catheter, Guidewire, Heart Valve, Event Monitor, and Others); Application, End User, and Country" report has been added to ResearchAndMarkets.com's offering.

The Asia Pacific cardiovascular devices market is expected to reach US$ 16,107.3 Mn in 2027 from US$ 8,852.6 Mn in 2018. The market is estimated to grow with a CAGR of 7.0% from 2019-2027.

The growth of the cardiovascular devices market is primarily attributed to the increasing acquisitions and collaboration activities and the increasing rate of obesity. However, a shortage of skilled workers is likely to pose a negative impact on market growth. On the other hand, growth opportunities in the developing nations and declining prices of coronary stents are likely to have a positive impact on the growth of the Asia Pacific cardiovascular devices market in the coming years. 

In 2018, the event monitor segment held the largest market share of 24.5% of the cardiovascular devices market, by the device. The event monitor segment is expected to dominate its market share in 2027 owing to the advantages offered such as easy monitoring and recording the cardiac rhythms of the patients. The ECG segment is anticipated to witness the fastest growth rate of 8.3% during the forecast period, 2019 to 2027 owing to the technological advancements in the medical devices that allow the diagnose the heartbeat in less time also the development has enabled to produce small and handy ECG devices.

In 2018, the coronary heart disease held the largest market share of 41.8% of the cardiovascular devices market, by the application. The coronary heart disease segment is expected to dominate its market share in 2027 owing to the rising prevalence of the disease. However, the stroke segment is anticipated to witness the fastest growth rate of 7.9% during the forecast period, 2019 to 2027. 

In 2018, the hospitals held the largest market share of 61.9% of the cardiovascular devices market, by the end user. This segment is also expected to dominate the market in 2027 owing to the need for cardiovascular surgery treatments that has become the major factor for the growth of the cardiovascular devices market. Also, the hospital's segment is expected to grow at the fastest growth rate of 7.2% during the forecast period, 2019 to 2027.

Key Topics Covered: 

1. Introduction
1.1 Scope Of The Study
1.2 Research Report Guidance

2. Asia Pacific Cardiovascular Devices Market - Key Takeaways

3. Asia Pacific Cardiovascular Devices Market - Market Landscape
3.1 Overview
3.2 Market Segmentation
3.3 Pest Analysis

4. Asia Pacific Cardiovascular Devices Market - Key Market Dynamics
4.1 Key Market Drivers
4.1.1 Increasing Acquisitions and Collaboration Activities
4.1.2 Increasing Rate of Obesity
4.2 Key Market Restraints
4.2.1 Shortage of Skilled Workers
4.3 Key Market Opportunities
4.3.1 Growth Opportunities in The Developing Nations
4.3.2 Declining Prices of Coronary Stents
4.4 Future Trends
4.4.1 Increasing Prevalence of Obesity Across The Region
4.5 Impact Analysis

5. Cardiovascular Devices Market - Asia Pacific Analysis
5.1 Asia Pacific Cardiovascular Devices Market Revenue Forecasts And Analysis
5.2 Market Positioning
5.2.1 Medtronic
5.2.2 Abbott

6. Asia Pacific Cardiovascular Devices Market Analysis - By Device
6.1 Overview
6.2 Asia Pacific Cardiovascular Devices Market By Device, 2018 & 2027 (%)
6.3 Asia Pacific Cardiovascular Devices Market Revenue And Forecasts To 2027, By Device (Us$ Mn)
6.4 Asia Pacific Cardiovascular Devices Volume Revenue And Forecasts To 2027, By Device (Units)
6.5 Event Monitor Market
6.6 Electrocardiography (Ecg) Market
6.7 Cardiac Catheter Market
6.8 Stent Market
6.9 Defibrillator Market
6.10 Guidewire Market
6.11 Pacemaker Market
6.12 Heart Valve Market
6.13 Other Devices Market

7. Asia Pacific Cardiovascular Devices Market Analysis - By Application
7.1 Overview
7.2 Asia Pacific Cardiovascular Devices Market, By Application, 2018 & 2027 (%)
7.3 Asia Pacific Cardiovascular Devices Market Revenue And Forecasts To 2027, By Application (Us$ Mn)
7.4 Coronary Heart Disease Market
7.5 Stroke Market
7.6 Sudden Cardiac Arrest Market
7.7 Cerebrovascular Heart Disease Market
7.8 Others Market

8. Asia Pacific Cardiovascular Devices Market Analysis - By End User
8.1 Overview
8.2 Asia Pacific Cardiovascular Devices Market, By End User, 2018 & 2027 (%)
8.3 Asia Pacific Cardiovascular Devices Market Revenue And Forecasts To 2027, By End User (Us$ Mn)
8.4 Hospitals Market
8.5 Cardiac Centers Market
8.6 Ambulatory Surgery Centers Market

9. Asia Pacific Cardiovascular Devices Market Revenue And Forecasts To 2027
9.1 Overview
9.2 Asia Pacific Cardiovascular Devices Market Revenue And Forecasts To 2027 (US$ Mn)
9.3 Asia Pacific Cardiovascular Devices Market Revenue And Forecasts To 2027, By Device (Us$ Mn)
9.4 Asia Pacific Cardiovascular Devices Volume Revenue And Forecasts To 2027, By Device (Units)
9.5 Asia Pacific Cardiovascular Devices Market Revenue And Forecasts To 2027, By End User (Us$ Mn)
9.6 Asia Pacific Cardiovascular Devices Market Revenue And Forecasts To 2027, By Country (%)

10. Cardiovascular Devices Market - Industry Landscape
10.1 Overview
10.2 Growth Strategies Done By The Companies In The Market, (%)
10.3 Organic Growth Strategies
10.3.1 Overview
10.3.2 Product Launch & Up-Gradation
10.3.3 Approvals
10.3.4 Others Developments
10.4 Inorganic Growth Strategies
10.4.1 Overview
10.4.2 Acquisition
10.4.3 Collaboration & Agreement

11. Cardiovascular devices Market-Key Company Profiles

  • Medtronic
  • Boston Scientific Corporation
  • Abbott
  • Biosense Webster, Inc. (Johnson and Johnson)
  • General Electric Company
  • Koninklijke Philips N.V
  • Siemens AG,
  • BD
  • Braun Melsungen AG
  • Edwards Lifesciences Corporation

 

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account



Podcast

 

Survey Box

Is Pharma innovation getting inhibited in APAC?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls